IP Library › Granted Patent US 11,512,060
Granted Patent B2
US 11,512,060 · App. 17/192,279 · Granted Nov 29, 2022

1,2,4-oxadiazole derivatives as immunomodulators

Inventors: Pottayil Govindan Nair Sasikumar (Bangalore, IN); Muralidhara Ramachandra (Bangalore, IN); Seetharamaiah Setty Sudarshan Naremaddepalli (Bangalore, IN)
Assignee: Aurigene Discovery Technologies Limited
C07D271/06A61K31/395A61K31/4245A61K31/433A61K45/06C07D273/00C07D273/08Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,512,060
App. No.
17/192,279
Granted
Nov 29, 2022
Kind
B2
Abstract

The present invention relates to pharmaceutical compositions of 1,2,4-oxadiazole compounds or a pharmaceutically acceptable salt thereof of formula (I) In the formula Q is O, R 1 is the side chain of Ser, R 2 is —CO-Thr, R 3 is the side chain of Asn or Glu, and R 4 , R 5 and R 6 are each H.

Claims (6)

1. A pharmaceutical composition comprising a compound and a pharmaceutically acceptable excipient, wherein the compound is

or a pharmaceutically acceptable salt thereof.

2. The pharmaceutical composition of claim 1 , wherein the compound is

3. The pharmaceutical composition of claim 1 , wherein the compound is a pharmaceutically acceptable salt of

4. The pharmaceutical composition of claim 1 , wherein the compound is

5. The pharmaceutical composition of claim 1 , wherein the compound is a pharmaceutically acceptable salt of

Assignments (1)
CHANGE OF NAME Recorded May 16, 2023
From: AURIGENE DISCOVERY TECHNOLOGIES LIMITED
To: AURIGENE ONCOLOGY LIMITED
Reel/Frame 063654/0411 →
Priority Claims (1)
IN 4011/CHE/2013 · Sep 6, 2013 · national
Continuity (6)
Continuation 16806872 · Mar 2, 2020
Continuation 16192030 · Nov 15, 2018
Continuation 15713671 · Sep 24, 2017
Continuation 15298539 · Oct 20, 2016
Continuation 14478759 · Sep 5, 2014
Related Publication 20210198219A1 · Jul 1, 2021
Cited By (1)
US 12,643,870